183 related articles for article (PubMed ID: 34407586)
1. [Activity comparison of humanized CD19 CAR-T cells with murine CD19 CAR-T on Nalm-6 cells and xenograft tumor model].
Wang J; Mou N; Meng JX; Li X; Jiang YY; Yuan T; Deng Q
Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):827-832. PubMed ID: 34407586
[No Abstract] [Full Text] [Related]
2. [In vitro studies on the transfer of CAR into leukemia cells due to their residue in the autologous CAR-T cell preparation system for acute B-cell acute lymphoblastic leukemia].
Liu MJ; Mu J; Yuan T; Cui R; Meng JX; Jiang YY; Li YM; Deng Q
Zhonghua Xue Ye Xue Za Zhi; 2021 Feb; 42(2):140-145. PubMed ID: 33858045
[No Abstract] [Full Text] [Related]
3. Efficacy and safety of humanized CD19 CAR-T as a salvage therapy for recurrent CNSL of B-ALL following murine CD19 CAR-T cell therapy.
Li X; Liu MJ; Mou N; Yang ZX; Wang J; Mu J; Zhu HB; Deng Q
Oncol Lett; 2021 Nov; 22(5):788. PubMed ID: 34584566
[TBL] [Abstract][Full Text] [Related]
4. [Construction and in vitro verification of a new humanized anti-CD19 CAR-T cells with high affinity].
Zhang CX; Cheng H; Han X; Qi KM; Chen W; Wu QY; Cao J; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2018 Jun; 39(6):465-470. PubMed ID: 30032561
[No Abstract] [Full Text] [Related]
5. [Maintenance therapy following CD19 CAR-T treatment for relapsed B-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation].
Jiang YL; Li Q; Pu YD; Jiang YY; Yuan T; Deng Q; Li YM; Han MZ; Zhai WH
Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):495-501. PubMed ID: 32654464
[No Abstract] [Full Text] [Related]
6. [Establishment of a cytokine release syndrome associated with chimeric antigen receptor T cell treatment in SCID/Beige mice model].
Shan JQ; Nan SF; Li F; Shen CY; Zhang Y
Zhonghua Zhong Liu Za Zhi; 2021 Dec; 43(12):1248-1254. PubMed ID: 34915632
[No Abstract] [Full Text] [Related]
7. Construction of a new anti-CD19 chimeric antigen receptor and the anti-leukemia function study of the transduced T cells.
An N; Tao Z; Li S; Xing H; Tang K; Tian Z; Rao Q; Wang M; Wang J
Oncotarget; 2016 Mar; 7(9):10638-49. PubMed ID: 26840021
[TBL] [Abstract][Full Text] [Related]
8. CD19 chimeric antigen receptor T cell therapy in leukemia xenograft mouse: Anti-leukemic efficacy, kinetics, and 4-week single-dose toxicity.
Kim JI; Park MY; Kwon E; Kang HJ; Kang BC
Toxicol Appl Pharmacol; 2023 Sep; 475():116628. PubMed ID: 37506978
[TBL] [Abstract][Full Text] [Related]
9. [Optimization of CD19 chimeric antigen receptor T cell establishment and observation of the killing effect in vitro and in vivo].
Ren CX; Chen XX; Zhao L; Tian Y; Xu KL; Zhao K
Zhonghua Xue Ye Xue Za Zhi; 2022 Jun; 43(6):506-512. PubMed ID: 35968595
[No Abstract] [Full Text] [Related]
10. [Effects of glucocorticoids on the proliferation of CD19 CAR-T cells targeting B-cell tumor cell lines].
Deng HB; Liu MJ; Jiang YY; Yuan T; Zhang R; Deng Q
Zhonghua Xue Ye Xue Za Zhi; 2021 Sep; 42(9):747-751. PubMed ID: 34753229
[No Abstract] [Full Text] [Related]
11. Direct and Indirect Chimeric Antigen Receptor T-Cell Imaging with PET/MRI in a Tumor Xenograft Model.
Kim SY; Soh H; Jung JH; Cho EH; Kim H; Ju JM; Sheen JH; Lee SJ; Oh SJ; Lee SJ; Chung J; Ryu JS
Radiology; 2024 Feb; 310(2):e231406. PubMed ID: 38411517
[TBL] [Abstract][Full Text] [Related]
12. [Effect of PD-1 inhibitor Nivolumab on the proliferation and cytotoxicity of anti-CD19 chimeric antigen receptor T cells].
Zhu HB; Deng Q; Zhang R; Jiang YY; Meng JX; Zhao MF; Li YM; Cui R
Zhonghua Xue Ye Xue Za Zhi; 2018 Jul; 39(7):584-588. PubMed ID: 30122019
[No Abstract] [Full Text] [Related]
13. Development of optimized cytotoxicity assays for assessing the antitumor potential of CAR-T cells.
Eugene-Norbert M; Cuffel A; Riou G; Jean L; Blondel C; Dehayes J; Bisson A; Giverne C; Brotin E; Denoyelle C; Poulain L; Boyer O; Martinet J; Latouche JB
J Immunol Methods; 2024 Feb; 525():113603. PubMed ID: 38147898
[TBL] [Abstract][Full Text] [Related]
14. [Humanized BCMA CAR-T cell salvage therapy in two refractory multiple myeloma patients who progressed after their murine BCMA CAR-T cell therapy].
Cui R; Li P; Li Q; Mu J; Jiang YL; Jiang YY; Deng Q
Zhonghua Xue Ye Xue Za Zhi; 2021 Jun; 42(6):502-507. PubMed ID: 34384157
[No Abstract] [Full Text] [Related]
15. Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies.
Ying Z; He T; Wang X; Zheng W; Lin N; Tu M; Xie Y; Ping L; Zhang C; Liu W; Deng L; Wu M; Feng F; Leng X; Du T; Qi F; Hu X; Ding Y; Lu XA; Song Y; Zhu J
BMC Cancer; 2021 Feb; 21(1):198. PubMed ID: 33632155
[TBL] [Abstract][Full Text] [Related]
16. [Effect of Special Structure Bi-Specific Chimeric Antigen Receptor T Cell on Tumor Cells].
Liu C; Peng H; Zeng WJ; Li W; Chen KK; Li WT; Zeng GF; Liang X; Hu JY; Zhou M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1730-1740. PubMed ID: 36476896
[TBL] [Abstract][Full Text] [Related]
17. [Effects of sodium iodide symporter co-expression on proliferation and cytotoxic activity of chimeric antigen receptor T cells
Tian C; Huang P; He Y; Wang L; Peng Z
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jul; 42(7):1062-1068. PubMed ID: 35869771
[TBL] [Abstract][Full Text] [Related]
18. Preclinical Assessment of Efficacy and Safety Analysis of CAR-T Cells (ISIKOK-19) Targeting CD19-Expressing B-Cells for the First Turkish Academic Clinical Trial with Relapsed/Refractory ALL and NHL Patients.
Taştan C; Kançağı DD; Turan RD; Yurtsever B; Çakırsoy D; Abanuz S; Yılancı M; Seyis U; Özer S; Mert S; Kayhan CK; Tokat F; Açıkel Elmas M; Birdoğan S; Arbak S; Yalçın K; Sezgin A; Kızılkılıç E; Hemşinlioğlu C; İnce Ü; Ratip S; Ovalı E
Turk J Haematol; 2020 Nov; 37(4):234-247. PubMed ID: 32755128
[TBL] [Abstract][Full Text] [Related]
19. [The specific cytotoxicities of chimeric antigen receptor-engineered T cells on different lymphomas].
Zhang R; Deng Q; Sui SN; Jin X; Zhao MF
Zhonghua Xue Ye Xue Za Zhi; 2017 Oct; 38(10):842-847. PubMed ID: 29166735
[No Abstract] [Full Text] [Related]
20. Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line.
Kang CH; Kim Y; Lee HK; Lee SM; Jeong HG; Choi SU; Park CH
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
